Elicio Therapeutics
Price & Volume
Stats
See more52W Range | $1.70-$16 |
Market Cap | $48.3M |
Shares Short | 1M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$2.15 |
News
See moreYahoo Finance • last month
Elicio Therapeutics to Participate at the Wells Fargo 21st Annual Healthcare Conference
Yahoo Finance • 3 months ago
Elicio Therapeutics drops 5%, prices $15M direct offering
Yahoo Finance • 3 months ago
Elicio Therapeutics Announces Pricing of $15 Million Registered Direct Offering
Yahoo Finance • 3 months ago
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Elicio Therapeutics, Inc. - ELTX
About
CEO | Mr. Robert T. Connelly |
Address | 451 D Street, Boston, MA, United States, 02210 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 33 |